PIŚMIENNICTWO
1. Griffin M.A., Culp W.T.N., Rebhun R.B.: Lower urinary tract neoplasia. Vet Sci., 2018, 5 (4).
2. Knapp D.W., Dhawan D., Ramos-Vara J.A., Ratliff T.L., Cresswell G.M., Utturkar S. i wsp.: Naturally-Occurring Invasive Urothelial Carcinoma in Dogs, a Unique Model to Drive Advances in Managing Muscle Invasive Bladder Cancer in Humans. Front Oncol [Internet], 2020, Jan 21 [cited 2021 Oct 2], 9, 1493. Available from: /pmc/articles/PMC6985458/
3. Knapp D.W., Glickman N.W., DeNicola D.B., Bonney P.L., Lin T.L., Glickman L.T.: Naturally-occurring canine transitional cell carcinoma of the urinary bladder. A relevant model of human invasive bladder cancer. Urol Oncol Semin Orig Investig [Internet], 2000, Mar 1 [cited 2021 Oct 2], 5 (2), 47–59. Available from: https://linkinghub.elsevier.com/retrieve/pii/S107814399900006X
4. Iizuka K., Shoji K., Fujiyuki T., Moritoh K., Tamura K., Yoshida A. i wsp.: Antitumor activity of an oncolytic measles virus against canine urinary bladder transitional cell carcinoma cells. Res Vet Sci [Internet], 2020, 133, 313-7. Available from: https://doi.org/10.1016/j.rvsc.2020.10.016
5. Davis B.W., Ostrander E.A.: Domestic Dogs and Cancer Research: A Breed-Based Genomics Approach. ILAR J [Internet], 2014 [cited 2021 Oct 2], 55 (1), 59. Available from: /pmc/articles/PMC4158346/
6. Fulkerson C.M., Knapp D.W.: Management of transitional cell carcinoma of the urinary bladder in dogs: A review. Vet J [Internet], 2015, 205 (2), 217-25. Available from: http://dx.doi.org/10.1016/j.tvjl.2015.01.017
7. Mutsaers A.J., Widmer W.R., Knapp D.W.: Canine Transitional Cell Carcinoma. J Vet Intern Med [Internet], 2003, Mar 1 [cited 2021 Oct 2], 17 (2), 136-44. Available from: https://onlinelibrary.wiley.com/doi/full/10.1111/j.1939-1676.2003.tb02424.x
8. Mochizuki H., Shapiro S.G., Breen M.: Detection of BRAF Mutation in Urine DNA as a Molecular Diagnostic for Canine Urothelial and Prostatic Carcinoma. Scarpa A, editor. PLoS One [Internet], 2015, Dec 9 [cited 2021 Oct 2], 10 (12), e0144170. Available from: https://pubmed.ncbi.nlm.nih.gov/26649430/
9. McCaw D.L., Hogan P.M., Shaw D.P.: Canine urinary bladder transitional call carcinoma with skull metastasis and unusual pulmonary metastases. Can. Vet. J., 1988.
10. Knapp D., McMillan S.: Tumors of the Urinary System. W: Withrow S.J., Vail D.M., Page R.L., editors. Withrow & MacEwen’s Small Animal Clinical Oncology. 5th ed. St. Louis, MO, USA: Elsevier, 2013, 572-82.
11. Morris J., Dobson J.: Small animal oncology. First edition, Blackwell Science Ltd, 2001.
12. Mohammed S.I., Dhawan D., Abraham S., Snyder P.W., Waters D.J., Craig B.A. i wsp.: Cyclooxygenase inhibitors in urinary bladder cancer: in vitro and in vivo effects. Mol Cancer Ther [Internet], 2006, Feb 1 [cited 2021 Oct 2], 5 (2), 329-36. Available from: https://mct.aacrjournals.org/content/5/2/329
13. Mohammed S.I., Craig B.A., Mutsaers A.J., Glickman N.W., Snyder P.W., DeGortari A.E. i wsp.: Effects of the cyclooxygenase inhibitor, piroxicam, in combination with chemotherapy on tumor response, apoptosis, and angiogenesis in a canine model of human invasive urinary bladder cancer. Mol Cancer Ther [Internet], 2003, Feb [cited 2021 Oct 2], 2 (2), 183-8. Available from: http://www.ncbi.nlm.nih.gov/pubmed/12589035
14. Bostrom P.J., van Rhijn B.W.G., Fleshner N., Finelli A., Jewett M., Thoms J. i wsp.: Staging and Staging Errors in Bladder Cancer. Eur Urol Suppl [Internet], 2010, Apr [cited 2021 Oct 2], 9 (1), 2-9.
15. Gustafson T.L., Biller B.: Use of Toceranib Phosphate in the Treatment of Canine Bladder Tumors: 37 Cases. Journal of the American Animal Hospital Association, 2019, 55 (5), 243-248. doi:10.5326/jaaha-ms-6905
